Early identification of adverse drug reactions from search log data

Journal of Biomedical Informatics

Volumn 59, Issue , 2016, Pages 42-48

  White, Ryen W ^a   Wang, Sheng ^b   Pant, Apurv ^c   Harpaz, Rave ^d   Shukla, Pushpraj ^c   Sun, Walter ^c   DuMouchel, William ^d   Horvitz, Eric ^a  

^a MICROSOFT RESEARCH   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c MICROSOFT   (United States)

^d Oracle Health Sciences   (United States)

Author keywords

Adverse drug reactions; Pharmacovigilance; Search log analysis

Indexed keywords

COMPUTER APPLICATIONS;

ADVERSE DRUG REACTION (ADRS); ADVERSE DRUG REACTIONS; AGGREGATED DATUM; INTERNET ARCHIVE; LOG ANALYSIS; NEGATIVE CONTROL; ON-LINE CONTENTS; PHARMACOVIGILANCE;

PHARMACODYNAMICS;

ADVERSE DRUG REACTION; ARTICLE; DRUG SURVEILLANCE PROGRAM; INFORMATION CENTER; INFORMATION RETRIEVAL; INTERNET; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEARCH ENGINE; SIGNAL DETECTION; CLASSIFICATION; FACTUAL DATABASE; HUMAN; MEDICAL INFORMATICS; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATABASES, FACTUAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; MEDICAL INFORMATICS COMPUTING; PHARMACOVIGILANCE; UNITED STATES;

EID: 84961653821     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2015.11.005     Document Type: Article

References (49)

1. Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J. Am. Med. Assoc. 1998, 279(15):1200-1205.
2. Classen D.C., Pestotnik S.L., Evans R.S., Lloyd J.F., Burke J.P. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. J. Am. Med. Assoc. 1997, 277(4):301-306.
3. Ahmad S.R. Adverse drug event monitoring at the food and drug administration. J. Gen. Intern. Med. 2003, 18(1):57-60.
4. Harpaz R., DuMouchel W., Shah N.H., Madigan D., Ryan P., Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Nat. Clin. Pharmacol. Therap. 2012, 91(6):1010-1021.
5. Szarfman A., Machado S.G., O'Neill R.T. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf. 2002, 25(6):381-392.
6. Harpaz R., DuMouchel W., LePendu P., Bauer-Mehren A., Ryan P., Shah N.H. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Nat. Clin. Pharmacol. Therap. 2013, 93(6):539-546.
7. Platt R., Wilson M., Chan K.A., Benner J.S., Marchibroda J., McClellan M. The new sentinel network: improving the evidence of medical-product safety. N. Engl. J. Med. 2009, 361(7):645-647.
8. Coloma P.M., Schuemie M.J., Trifirò G., Gini R., Herings R., Hippisley-Cox J., Mazzaglia G., Giaquinto C., Corrao G., Pedersen L., van der Lei J., Sturkenboom M. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EUADR Project. Pharmacoepidemiol. Drug Saf. 2011, 20(1):1-11. EU-ADR Consortium.
9. Stang P.E., Ryan P.B., Racoosin J.A., Overhage J.M., Hartzema A.G., Reich C., Welebob E., Scarnecchia T., Woodcock J. Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership. Ann. Intern. Med. 2010, 153(9):600-606.
10. Shetty K.D., Dalal S.R. Using information mining of the medical literature to improve drug safety. J. Am. Med. Inform. Assoc. 2011, 18(5):668-674.
11. Avillach P., Dufour J.C., Diallo G., Salvo F., Joubert M., Thiessard F., Mougin F., Trifirò G., Fourrier-Réglat A., Pariente A., Fieschi M. Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project. J. Am. Med. Inform. Assoc. 2013, 20(3):446-452.
12. Pontes H., Clement M., Rollason V. Safety signal detection: the relevance of literature review. Drug Saf. 2014, 37(7):471-479.
13. Vilar S., Harpaz R., Chase H.S., Costanzi S., Rabadan R., Friedman C. Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis. J. Am. Med. Inform. Assoc. 2011, 18(1):73-80.
14. Chiang A.P., Butte A.J. Data-driven methods to discover molecular determinants of serious adverse drug events. Nat. Clin. Pharmacol. Therap. 2009, 85(3):259-268.
15. M. De Choudhury, M.R. Morris, R.W. White, Seeking and sharing health information online: comparing search engines and social media, in: Proceedings of the SIGCHI Conference on Human Factors in Computing Systems, 2014, pp. 1365-1376.
16. Harpaz R., Callahan A., Tamang S., Low Y., Odgers D., Finlayson S., Jung K., LePendu P., Shah N.H. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf. 2014, 37(10):777-790.
17. R. Leaman, L. Wojtulewicz, R. Sullivan, A. Skariah, J. Yang, G. Gonzalez, Towards internet-age pharmacovigilance: extracting adverse drug reactions from user posts in health-related social networks, in: Proceedings of the 2010 Workshop on Biomedical Natural Language Processing, 2010, pp. 117-125.
18. Wicks P., Vaughan T.E., Massagli M.P., Heywood J. Accelerated clinical discovery using self-reported patient data collected online and a patient matching algorithm. Nat. Biotechnol. 2011, 29(5):411-414.
19. Pew Research Center. Pew Internet & American Life Project: Health Online 2013. (Accessed July 2015). http://www.pewinternet.org/2013/01/15/health-online-2013.
20. Ginsberg J., Mohebbi M.H., Patel R.S., Brammer L., Smolinski M.S., Brilliant L. Detecting influenza epidemics using search engine query data. Nature 2009, 457:1012-1014.
21. White R.W., Tatonetti N.P., Shah N.H., Altman R.B., Horvitz E. Web-scale pharmacovigilance: listening to signals from the crowd. J. Am. Med. Inform. Assoc. 2013, 20(3):404-408.
22. White R.W., Harpaz R., Shah N.H., DuMouchel W., Horvitz E. Toward enhanced pharmacovigilance using patient-generated data on the internet. Nat. Clin. Pharmacol. Therap. 2014, 96(2):239-246.
23. Yom-Tov E., Gabrilovich E. Post-market drug surveillance without trial costs: discovery of adverse drug reactions through large-scale analysis of web search queries. J. Med. Internet Res. 2013, 15(6):e124.
24. Butler D. When Google got flu wrong. Nature 2013, 494(7436):155-156.
25. Cook S., Conrad C., Fowlkes A.L., Mohebbi M.H. Assessing Google flu trends performance in the United States during the 2009 influenza virus A (H1N1) pandemic. PLoS ONE 2011, 6(8):e23610.
26. Lazer D., Kennedy R., King G., Vespigiani A. The parable of Google flu: traps in big data analysis. Science 2014, 343(6176):1203-1205.
27. Watts D. A simple model of global cascades on random networks. Proc. Natl. Acad. Sci. 2002, 99(9):5766.
28. E. Bakshy, B. Karrer, L.A. Adamic, Social influence and the diffusion of user-created content, in: Proceedings of the ACM Conference on Electronic Commerce, 2009, pp. 325-334.
29. Ryan P.B., Stang P.E., Overhage J.M., Suchard M.A., Hartzema A.G., DuMouchel W., Reich C.G., Schuemie M.J., Madigan D. A comparison of the empirical performance of methods for a risk identification system. Drug Saf. 2013, 36(1):143-158.
30. Noren G.N., Caster O., Juhlin K., Lindquist M. Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf. 2014, 37(9):655-659.
31. Harpaz R., DuMouchel W., Shah N.H. Comment on: "Zoo or Savannah? Choice of training ground for evidence-based pharmacovigilance". Drug Saf. 2015, 38(1):113-114.
32. Harpaz R., Odgers D., Gaskin G., DuMouchel W., Winnenburg R., Bodenreider O., Ripple A., Szarfman A., Sorbello A., Horvitz E., White R.W., Shah N.H. A time-indexed reference standard of adverse drug reactions. Nat. Sci. Data 2014, 1.
33. D. Downey, S.T. Dumais, E. Horvitz, Models of searching and browsing: Languages, studies, and application, in: Proceedings of the International Joint Conference on Artificial Intelligence, 2007, pp. 2740-2747.
34. R.W. White, S.M. Drucker, Investigating behavioral variability in web search, in: Proceedings of the 16th International Conference on World Wide Web, 2007, pp. 21-30.
35. D.J. Odgers, R. Harpaz, A. Callahan, G. Stiglic, N.H. Shah, Analyzing search behavior of healthcare professionals for drug safety surveillance, in: Proceedings of Pacific Symposium on Biocomputing, 2014, pp. 306-317.
36. MedWatch, (Accessed July 2015). http://www.fda.gov/Safety/MedWatch.
37. E. Adar, J. Teevan, S.T. Dumais, Large scale analysis of web revisitation patterns, in: Proceedings of the SIGCHI Conference on Human Factors in Computing Systems, 2008, pp. 1197-1206.
38. D.J. Liebling, P.N. Bennett, R.W. White, Anticipatory search: using context to initiate search, in: Proceedings of the 35th International ACM SIGIR Conference on Research and Development in Information Retrieval, 2012, pp. 1035-1036.
39. Y. Ustinovskiy, P. Serdyukov, Personalization of web-search using short-term browsing context, in: Proceedings of the 22nd ACM International Conference on Information and Knowledge Management, 2013, pp. 1979-1988.
40. D. Beeferman, A. Berger, Agglomerative clustering of a search engine query log, in: Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 2000, pp. 407-416.
41. Richardson M. Learning about the world through long-term query logs. ACM Trans. Web 2008, 2(4):21.
42. Bate A., Evans S.J.W. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol. Drug Saf. 2009, 18(6):427-436.
43. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
44. R. Harpaz, W. DuMouchel, P. LePendu, N.H. Shah, Empirical Bayes model to combine signals of adverse drug reactions, in: Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 2013, pp. 1339-1347.
45. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am. Stat. 1999, 53(3):177-190.
46. W. DuMouchel, D. Pregibon, Empirical Bayes screening for multi-item associations, in: Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 2001, pp. 67-76.
47. Haider S.I., Johnell K., Thorslund M., Fastbom J. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002. Int. J. Clin. Pharmacol. Ther. 2007, 45(12):643-665.
48. Ryan P.B., Madigan D., Stang P.E., Marc O.J., Racoosin J.A., Hartzema A.G. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the observational medical outcomes partnership. Stat. Med. 2012, 31(30):4401-4415.
49. M.J. Paul, R.W. White, E. Horvitz, Diagnoses, decisions, and outcomes: Web search as decision support for cancer, in: Proceedings of the 24th International Conference on World Wide Web, 2015, pp. 831-841.